StockData

Actinium Pharmaceuticals vs Incannex Healthcare

ATNM and IXHL side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ATNM and IXHL compare

Actinium Pharmaceuticals is the larger company, worth 1.9 times as much as Incannex Healthcare ($42.4M against $21.8M).

Actinium Pharmaceuticals scores higher on the StockData Score (10 against 7 for Incannex Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricATNMIXHL
Size and price
Market cap$42.4M$21.8M
Share price$1.35$1.74
Change, 1 year6.3%−83.5%
Change, 5 years−81.5%–
Beta (5Y)1.382.40
Employees2512
StockData Score
Total score10 (better)7
Valuation score4 (better)1
Growth score00
Performance score11
Health score55
Dividend score00
Valuation
P/E3.8×–
P/B1.4×0.3× (better)
EV/EBITDA0.6×–
FCF yield–−14.6%
Fair value$7.16–
Margin of safety81.1%–
Profitability
Return on equity45.9% (better)−20.7%
Return on invested capital–−1945%
Financial health
Debt / equity0.000.00
Current ratio4.0867.79 (better)
Altman Z-score−9.28−0.22 (better)
Piotroski F-score24 (better)
Dividends and buybacks
Buyback yield–−42.2%
Shareholder yield0.00% (better)−42.2%
Ownership
Held by institutions16.8%3.6%
Held by insiders5.9%–
Short interest, % of float2.0%–

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.